Arcellx (ACLX) EBT Margin (2023 - 2025)

Arcellx's (ACLX) quarterly EBT Margin came in at 3444.37% in Q4 2025, down 314582.0% year-on-year from N/an in Q4 2024, and down 205.59% quarter-over-quarter from 1127.12% in Q3 2025.

Arcellx (ACLX) EBT Margin (2023 - 2025) Analysis & Trends

Arcellx's EBT Margin history runs 3 years deep, the most recent figure standing at 3444.37% for Q4 2025.

  • On a quarterly basis, EBT Margin fell 314582.0% year-over-year to 3444.37% in Q4 2025; TTM through Dec 2025 was 1023.36%, a 92583.0% decrease from a year earlier, with the FY2025 full-year figure at 1026.95%, down 92941.0% from the prior year.
  • EBT Margin retreated to 3444.37% in Q4 2025 per ACLX's latest filing, from 1127.12% in the prior quarter.
  • Across five years, EBT Margin topped out at 32.41% in Q4 2023 and bottomed at 3444.37% in Q4 2025.
  • The 3-year median for EBT Margin is 215.9% (2023), against an average of 591.26%.
  • Across the five-year window, EBT Margin surged 16452 bps in 2024 and tumbled 314582 bps in 2025, its largest moves.
  • Year by year, EBT Margin stood at 32.41% in 2023, then slumped by 1021 bps to 298.55% in 2024, then slumped by 1054 bps to 3444.37% in 2025.
  • Per Business Quant, the three latest ACLX EBT Margin figures stand at 3444.37% (Q4 2025), 1127.12% (Q3 2025), and 693.97% (Q2 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 17.13%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 41.95%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.05%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 34.77%
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Arcellx 6.48 Bn 6.48 Bn - -3,444.37%

Historic Data

Download Data
DateValue
Dec 31, 2025 -3,444.37%
Sep 30, 2025 -1,127.12%
Jun 30, 2025 -693.97%
Mar 31, 2025 -766.02%
Dec 31, 2024 -298.55%
Sep 30, 2024 -98.52%
Jun 30, 2024 -98.09%
Mar 31, 2024 -18.34%
Dec 31, 2023 32.41%
Sep 30, 2023 -263.03%
Jun 30, 2023 -168.76%
Mar 31, 2023 -150.82%